Bera Sanjib, Malik Leila, Bhat Balkrishen, Carroll Steven S, MacCoss Malcolm, Olsen David B, Tomassini Joanne E, Eldrup Anne B
Department of Medicinal Chemistry, Isis Pharmaceuticals, Carlsbad, CA 92008, USA.
Bioorg Med Chem Lett. 2003 Dec 15;13(24):4455-8. doi: 10.1016/j.bmcl.2003.09.008.
A series of optically pure 1,3-dioxolane nucleoside mimics was synthesized by a synthetic route that allowed incorporation of a 5R-methyl substituent from commercially available starting materials. The pyrrolo[2,3-d]pyrimidine heterocycle was chosen as a substitute for the purine derivative. Coupling of the pyrrolo[2,3-d]pyrimidine and the dioxolane was performed under solid-liquid phase transfer conditions. The ability to inhibit HCV RNA replication was assessed in a cell based subgenomic replicon assay. None of the described compounds displayed significant anti-HCV activity.
通过一条合成路线合成了一系列光学纯的1,3 - 二氧戊环核苷类似物,该路线允许从市售起始原料引入5R - 甲基取代基。选择吡咯并[2,3 - d]嘧啶杂环作为嘌呤衍生物的替代物。吡咯并[2,3 - d]嘧啶与二氧戊环的偶联在固 - 液相转移条件下进行。在基于细胞的亚基因组复制子测定中评估了抑制丙型肝炎病毒(HCV)RNA复制的能力。所描述的化合物均未显示出显著的抗HCV活性。